Framingham Heart Study Bibliography

back to Framingham Main Bibliography Page back to Framingham Home Page

Years 1980-1989


  1. Yusuf S, Thom TJ, Abbott RD. Changes in hypertension treatment and in congestive heart failure mortality in the United States. Hypertension 1989;13:I74-I79.

  2. Wong ND, Cupples LA, Ostfeld AM, Levy D, Kannel WB. Risk factors for long-term coronary prognosis after initial myocardial infarction: the Framingham Study. Am.J.Epidemiol. 1989;130:469-80.

  3. Wilson PWF. The impact of estrogen on cardiovascular disease. Prospective studies: the Framingham Study. Postgrad.Med. 1989;Spec. No:51-53.

  4. Wilson PWF, Garrison RJ, Kannel WB, McGee DL, Castelli WP. Is coffee consumption a contributor to cardiovascular disease? Insights from the Framingham Study. Arch.Intern.Med. 1989;149:1169-72.

  5. Wilson PWF, Christiansen JC, Anderson KM, Kannel WB. Impact of national guidelines for cholesterol risk factor screening. The Framingham Offspring Study. JAMA 1989;262:41-44.

  6. Stokes JI, Kannel WB, Wolf PA, D'Agostino RB, Cupples LA. Blood pressure as a risk factor for cardiovascular disease. The Framingham Study--30 years of follow-up. Hypertension 1989;13:I13-I18.

  7. Sorlie PD, Kannel WB, O'Connor G. Mortality associated with respiratory function and symptoms in advanced age. The Framingham Study. Am.Rev.Respir.Dis. 1989;140:379-84.

  8. Schildkraut JM, Myers RH, Cupples LA, Kiely D, Kannel WB. Coronary risk associated with age and sex of parental heart disease in the Framingham Study. Am.J.Cardiol. 1989;64:555-59.

  9. Schatzkin A, Carter CL, Green SB, Kreger BE, Splansky GL, Anderson KM et al. Is alcohol consumption related to breast cancer? Results from the Framingham Heart Study. J.Natl.Cancer Inst. 1989;81:31-35.

  10. Schaefer EJ, Moussa PB, Wilson PWF, McGee DL, Dallal G, Castelli WP. Plasma lipoproteins in healthy octogenarians: lack of reduced high density lipoprotein cholesterol levels: results from the Framingham Heart Study. Metabolism 1989;38:293-96.

  11. Sawin CT, Geller A, Hershman JM, Castelli WP, Bacharach P. The aging thyroid. The use of thyroid hormone in older persons. JAMA 1989;261:18:2653-55.

  12. Sawin CT, Carlson HE, Geller A, Castelli WP, Bacharach P. Serum prolactin and aging: basal values and changes with estrogen use and hypothyroidism. J.Gerontol. 1989;44:M131-M135.

  13. Podgor MJ, Kannel WB, Cassel GH, Sperduto RD. Lens changes and the incidence of cardiovascular events among persons with diabetes. Am.Heart J. 1989;117:642-48.

  14. McNamara JR, Campos H, Adolphson JL, Ordovas JM, Wilson PWF, Albers JJ et al. Screening for lipoprotein[a] elevations in plasma and assessment of size heterogeneity using gradient gel electrophoresis. J.Lipid Res. 1989;30:747-55.

  15. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Left ventricular mass and incidence of coronary heart disease in an elderly cohort. The Framingham Heart Study. Ann.Intern.Med. 1989;110:101-07.

  16. Kreger BE, Anderson KM, Kannel WB. Prevalence of intraventricular block in the general population: the Framingham Study. Am.Heart J. 1989;117:903-10.

  17. Kelly-Hayes M, Wolf PA, Kase CS, Gresham GE, Kannel WB, D'Agostino RB. Time course of functional recovery after stroke: the Framingham Study. J.Neuro.Rehab. 1989;38:4:504-09.

  18. Kase CS, Wolf PA, Chodosh EH, Zacker HB, Kelly-Hayes M, Kannel WB et al. Prevalence of silent stroke in patients presenting with initial stroke: the Framingham Study. Stroke 1989;20:850-52.

  19. Kannel WB, D'Agostino RB. Risk reduction after quitting smoking., Quality of Life and Cardiovascular Care.. 1989. p. 84-85.

  20. Kannel WB, Thom TJ. Incidence, prevalence, and mortality of cardiovascular diseases, In: Hurst JW, editor. The Heart. Arteries and Veins, 7 ed. New York: McGraw-Hill Book Co.; 1989. p. 627-38.

  21. Kannel WB, Cupples LA. Cardiovascular and noncardiovascular consequences of obesity, In: Stunkard AJ, Baum A, editors. Perspectives in Behavioral Medicine. Eating, Sleeping, and Sex. New Jersey: Lawrence Erlbaum Associates, Publishers; 1989. p. 109-29.

  22. Kannel WB. Impact of risk factors, Consultant. 1989. p. 104-24.

  23. Kannel WB. Detection and management of patients with silent myocardial ischemia. Am.Heart J. 1989;117:221-26.

  24. Kannel WB, Carter BL. Initial drug therapy for hypertensive patients with hyperlipidemia. Am.Heart J. 1989;118:1012-21.

  25. Kannel WB. An integrated view of hypertension. J.Hum.Hypertens. 1989;3 Suppl 2:3-8.

  26. Kannel WB. Epidemiological aspects of heart failure. Cardiol.Clin. 1989;7:1-9.

  27. Kannel WB. Risk factors in hypertension. J.Cardiovasc.Pharmacol. 1989;13 Suppl 1:S4-S10.

  28. Havlik RJ, Blackwelder WC, Kaslow R, Castelli WP. Unlikely association between clinically apparent herpesvirus infection and coronary incidence at older ages. The Framingham Heart Study. Arteriosclerosis 1989;9:6:877-80.

  29. Gordon DJ, Probstfield JL, Garrison RJ, Neaton JD, Castelli WP, Knoke JD et al. High-density lipoprotein cholesterol and cardiovascular disease Four prospective American studies. Circulation 1989;79:8-15.

  30. Felson DT, Anderson JJ, Naimark A, Kannel WB, Meenan RF. The prevalence of chondrocalcinosis in the elderly and its association with knee osteoarthritis: the Framingham Study. J.Rheumato. 1989;16:9:1241-45.

  31. Felson DT, Anderson JJ, Naimark A, Hannan MT, Kannel WB, Meenan RF. Does smoking protect against osteoarthritis? Arthritis Rheum. 1989;32:166-72.

  32. Felson DT, Anderson JJ, Hannan MT, Milton RC, Wilson PWF, Kiel DP. Impaired vision and hip fracture. The Framingham Study. J.Am.Geriatr.Soc. 1989;37:495-500.

  33. Fabsitz R, Nam JM, Gart J, Stunkard A, Price RA, Wilson PWF. HLA associations with obesity. Hum.Hered. 1989;39:156-64.

  34. Eaker ED, Abbott RD, Kannel WB. Frequency of uncomplicated angina pectoris in type A compared with type B persons (the Framingham Study). Am.J.Cardiol. 1989;63:1042-45.

  35. Dannenberg AL, Keller JB, Wilson PWF, Castelli WP. Leisure time physical activity in the Framingham Offspring Study. Description, seasonal variation, and risk factor correlates. Am.J.Epidemiol. 1989;129:76-88.

  36. Dannenberg AL, Levy D, Garrison RJ. Impact of age on echocardiographic left ventricular mass in a healthy population (the Framingham Study). Am.J.Cardiol. 1989;64:1066-68.

  37. D'Agostino RB, Kannel WB. Epidemiological background and design: the Framingham Study, Proceedings of the American Statistical Association sesquicentennial invited paper sessions. 1989. p. 707-18.

  38. D'Agostino RB, Kannel WB, Belanger AJ, Sytkowski PA. Trends in CHD and risk factors at age 55-64 in the Framingham Study. Int.J.Epidemiol. 1989;18:S67-S72.

  39. Castelli WP, Wilson PWF, Levy D, Anderson KM. Cardiovascular risk factors in the elderly. Am.J.Cardiol. 1989;63:12H-9H.

  40. Campbell G, Levy D, Lausier A, Horton MR, Bailey JJ. Nonparametric comparison of entire ROC curves for computerized ECG left ventricular hypertrophy algorithms using data from the Framingham Heart Study. J.Electrocardiol. 1989;22 Suppl:152-57.

  41. Brand FN, Abbott RD, Kannel WB. Diabetes, intermittent claudication, and risk of cardiovascular events. The Framingham Study. Diabetes 1989;38:504-09.

  42. Abbott RD, Levy D, Kannel WB, Castelli WP, Wilson PWF, Garrison RJ et al. Cardiovascular risk factors and graded treadmill exercise endurance in healthy adults: the Framingham Offspring Study. Am.J.Cardiol. 1989;63:342-46.

  43. Wolf PA, D'Agostino RB, Kannel WB, Bonita R, Belanger AJ. Cigarette smoking as a risk factor for stroke. The Framingham Study. JAMA 1988;259:1025-29.

  44. Wilson PWF, Abbott RD, Castelli WP. High density lipoprotein cholesterol and mortality. The Framingham Heart Study. Arteriosclerosis 1988;8:737-41.

  45. Wilking SV, Belanger AJ, Kannel WB, D'Agostino RB, Steel K. Determinants of isolated systolic hypertension. JAMA 1988;260:3451-55.

  46. Vokonas PS, Kannel WB, Cupples LA. Epidemiology and risk of hypertension in the elderly: the Framingham Study. J.Hypertens.Suppl. 1988;6:S3-S9.

  47. Levy D. Left ventricular hypertrophy. Epidemiological insights from the Framingham Study. Drugs 1988;(Suppl 5):1-5.

  48. Levy D, Anderson KM, Christiansen JC, Campanile G, Stokes JI. Antihypertensive drug therapy and arrhythemia risk. Am.J.Cardiol. 1988;62:147-49.

  49. Levy D, Anderson KM, Savage DD, Kannel WB, Christiansen JC, Castelli WP. Echocardiographically detected left ventricular hypertrophy: prevalence and risk factors. The Framingham Heart Study. Ann.Intern.Med. 1988;108:7-13.

  50. Levy D, Kannel WB. Cardiovascular risks: new insights from Framingham. Am.Heart J. 1988;116:266-72.

  51. Kelly-Hayes M, Wolf PA, Kannel WB, Sytkowski PA, D'Agostino RB, Gresham GE. Factors influencing survival and need for institutionalization following stroke: the Framingham Study. Arch.Phys.Med.Rehabil. 1988;69:415-18.

  52. Kannel WB. Contributions of the Framingham Study to the conquest of coronary artery disease. Am.J.Cardiol. 1988;62:1109-12.

  53. Kannel WB. Nutritional considerations in occurrence and prevention of cardiovascular disease in the elderly, In: Ingram DK, Baker GTI, Shock NW, editors. The Potential for Nutritional Modulation of Aging Processes. New York: Food and Nutrition Press.; 1988. p. 17-49.

  54. Kannel WB. Lipids, nutrition, and cardiovascular disease in the elderly, In: Beare-Rogers J, editor. Dietary Fat and Requirements in Health and Developement. Illinois: American Oil Chemists' Society; 1988. p. 191-200.

  55. Kannel WB. Epidemiological insights into heart failure, Failing Heart Syndrome.Imperial Chemical Industries PLC, Publishers; 1988. p. 13-24.

  56. Kannel WB, Cupples LA. Silent myocardial infarction. Incidence, prevalence, and prognostic significance, In: Singh BN, editor. Silent Myocardial Ischemia and Angina. New York: Pergamon Press; 1988. p. 174-82.

  57. Kannel WB, Cupples AC. Epidemiology and risk profiles of cardiac failure. Cardiovascular Drugs and Therapy 1988;2:387-95.

  58. Kannel WB. Incidence and outlook for cardiac failure: perceptions from the Framingham Study. Journal for Drug Therapy and Research 1988;(Suppl 5):13:266-72.

  59. Kannel WB. The lipid-atherogenesis connection. 12 questions frequently asked by physicians. Consultant 1988;28:3:25-38.

  60. Kannel WB, Plehn JF, Cupples LA. Cardiac failure and sudden death in the Framingham Study. Am.Heart J. 1988;115:869-75.

  61. Kannel WB. Nutrition and the occurrence and prevention of cardiovascular disease in the elderly. Nutr.Rev. 1988;46:68-78.

  62. Kannel WB, Cupples LA, D'Agostino RB, Stokes JI. Hypertension, antihypertensive treatment, and sudden coronary death. The Framingham Study. Hypertension 1988;11:II45-II50.

  63. Kannel WB. Cholesterol and risk of coronary heart disease and mortality in men. Clin.Chem. 1988;34:B53-B59.

  64. Kannel WB. Alcohol and cardiovascular disease. Proc.Nutr.Soc. 1988;47:99-110.

  65. Jette AM, Pinsky JL, Branch LG, Wolf PA, Feinleib M. The Framingham Disability Study: physical disability among community-dwelling survivors of stroke. J.Clin.Epidemiol. 1988;41:8:719-26.

  66. Hiller R, Sperduto RD, Podgor MJ, Ferris FL, Wilson PWF. Diabetic retinopathy and cardiovascular disease in type II diabetics. Am.J.Epidemiol. 1988;128:402-09.

  67. Hiller R, Sperduto RD, Podgor MJ, Ferris FL, Wilson PWF. Diabetic retinopathy and cardiovascular disease in type III diabetics. The Framingham Heart Study and the Framingham Eye Study. Am.J.Epidemiol. 1988;128:402-09.

  68. Higgins MW, Kannel WB, Garrison RJ, Pinsky JL, Stokes JI. Hazards of obesity - the Framingham experience. Acta.Med.Scand. 1988;(Suppl 723):23-26.

  69. Hubert HB. The nature of the relationship between obesity and cardiovascular disease. Int J Cardiol 1984;6:268-74.

  70. Harris TB, Cook EF, Garrison RJ, Higgins MW, Kannel WB. Body mass index and mortality among nonsmoking older persons. JAMA 1988;259:10:1520-24.

  71. Harris TB, Cook EF, Kannel WB, Goldman L. Proportional hazards analysis of risk factors for coronary heart disease in individuals aged 65 or older. The Framingham Heart Study. J.Am.Geriatr.Soc. 1988;36:1023-28.

  72. Hands ME, Sia ST, Shook TL, Anderson KM, Stone PH, Levy D et al. Silent myocardial ischemia in asymptomatic survivors of unrecognized myocardial infarction and matched controls. Am.Heart J. 1988;116:1488-92.

  73. Felson DT. Epidemiology of hip and knee osteosarthritis. Epidemiologic Reviews 1988;10:1-28.

  74. Felson DT, Kiel DP, Anderson JJ, Naimark A, Walker AM, Meenan RF. Obesity and knee osteoarthritis. The Framingham Study. Ann.Intern.Med. 1988;109:1:18-24.

  75. Felson DT, Kiel DP, Anderson JJ, Kannel WB. Alcohol consumption and hip fractures: the Framingham Study. Am.J.Epidemiol. 1988;128:1102-10.

  76. Eaker ED, Castelli WP. Type A behavior and mortality from coronary disease in the Framingham Study. N.Engl.J.Med. 1988;319:1480-81.

  77. Eaker ED, Thom TJ, Castelli WP. Coronary heart disease in women. Soz.Praventivmed. 1988;33:10-16.

  78. Eaker ED, Castelli WP. Type A behavior and mortality from coronary disease in the Framingham Study [letter] [see comments]]. N.Engl.J.Med. 1988;319:1480-81.

  79. Dannenberg AL, Garrison RJ, Kannel WB. Incidence of hypertension in the Framingham Study. Am.J.Public Health 1988;78:676-79.

  80. Cupples LA, Ramaswamy R, Christiansen JC, Belanger AJ, D'Agostino RB. The Framingham Study: An Epidemiological Investigation of Cardiovascular Disease, Section 38: The Relationship Between Sporadically Measured Variables and the Risk of Cardiovascular Disease and Death: The Framingham Heart Study, 30-34 Year Follow- up. Bethesda, MD: National Heart, Lung, and Blood Institute; 1988.

  81. Cupples LA, D'Agostino RB, Kiely D. The Framingham Heart Study, Section 35. An Epidemiological Investigation of Cardiovascular Disease. Survival Following Cardiovascular Events: 30 Year Follow-up. Bethesda, MD: National Heart, Lung and Blood Institute; 1988.

  82. Cupples LA, D'Agostino RB, Anderson KM, Kannel WB. Comparison of baseline and repeated measure covariate techniques in the Framingham Heart Study. Stat.Med. 1988;7:205-18.

  83. Castelli WP. Cardiovascular disease in women. Am.J.Obstet.Gynecol. 1988;158:1553-60, 1566-7.

  84. Castelli WP. Cholesterol and lipids in the risk of coronary artery disease-- the Framingham Heart Study. Can.J.Cardiol. 1988;4 Suppl A:5A-10A.

  85. Campos H, McNamara JR, Wilson PWF, Ordovas JM, Schaefer EJ. Differences in low density lipoprotein subfractions and apolipoproteins in premenopausal and postmenopausal women. J.Clin.Endocrinol.Metab. 1988;67:30-35.

  86. Brehm HP, Rush TV. Disability analysis of longitudinal health data: Policy implications for social security insurance. Journal of Aging Studies 1988;2:4:379-99.

  87. Brand FN, Dannenberg AL, Abbott RD, Kannel WB. The epidemiology of varicose veins: the Framingham Study. Am.J.Prev.Med. 1988;4:96-101.

  88. Belanger AJ, Cupples LA, D'Agostino RB. The Framingham Study: The Epidemiological Investigation of Cardiovascular Disease, Section 36. Means at Each Examination and Inter-examination Consistency of Specified Characteristics. Framingham Heart Study: 30-year Follow-up. Bethesda, MD: National Heart, Lung, and Blood Institute; 1988.

  89. Abbott RD. Commentary on "comparison of baseline and repeated measure covariate techniques in the Framingham Heart Study". Stat.Med. 1988;7:219-22.

  90. Abbott RD, Brand FN, Kannel WB, Castelli WP. Gout and coronary heart disease: the Framingham Study. J.Clin.Epidemiol. 1988;41:237-42.

  91. Abbott RD, Wilson PWF, Kannel WB, Castelli WP. High density lipoprotein cholesterol, total cholesterol screening, and myocardial infarction. The Framingham Study. Arteriosclerosis 1988;8:207-11.

  92. Abbott RD, Donahue RP, Kannel WB, Wilson PWF. The impact of diabetes on survival following myocardial infarction in men vs women. The Framingham Study [published erratum appears in JAMA 1989 Apr 7;261(13):1884] [see comments]]. JAMA 1988;260:3456-60.

  93. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study. Arch.Intern.Med. 1987;147:1561-64.

  94. Wilson PWF, Castelli WP, Kannel WB. Coronary risk prediction in adults (the Framingham Heart Study) [published erratum appears in Am J Cardiol 1987 Nov 1;60(13):A11]]. Am.J.Cardiol. 1987;59:91G-4G.

  95. Willich SN, Levy D, Rocco MB, Tofler GH, Stone PH, Muller JE. Circadian variation in the incidence of sudden cardiac death in the Framingham Heart Study population. Am.J.Cardiol. 1987;60:801-06.

  96. Stokes JI, Kannel WB, Wolf PA, Cupples LA, D'Agostino RB. The relative importance of selected risk factors for various manifestations of cardiovascular disease among men and women from 35 to 64 years old: 30 years of follow-up in the Framingham Study. Circulation 1987;75(Suppl V):V65-V73.

  97. Sorlie PD, Lakatos E, Kannel WB, Celli B. Influence of cigarette smoking on lung function at baseline and at follow-up in 14 years: the Framingham Study. J.Chronic.Dis. 1987;40:849-56.

  98. Savage DD, Brand FN, Kannel WB. Does posterior extra-echocardiographic space always mean disease? Primary Cardiol. 1987;12-18.

  99. Savage DD, Garrison RJ, Kannel WB, Levy D, Anderson SJ, Stokes JI et al. The spectrum of left ventricular hypertrophy in a general population sample: the Framingham Study. Circulation 1987;75(Suppl I):I-26.

  100. Savage DD, Garrison RJ, Kannel WB, Anderson SJ, Feinleib M, Castelli WP. Considerations in the use of echocardiography in epidemiology. The Framingham Study. Hypertension 1987;9(Suppl II):II40-II44.

  101. Pinsky JL, Leaverton PE, Stokes JI. Predictors of good function: the Framingham Study. J.Chronic.Dis. 1987;40(Suppl 1):159S-67S.

  102. Ordovas JM, Litwack-Klein L, Wilson PWF, Schaefer MM, Schaefer EJ. Apolipoprotein E isoform phenotyping methodology and population frequency with identification of apoE1 and apoE5 isoforms. J.Lipid Res. 1987;28:371-80.

  103. Ordovas JM, Peterson JP, Santaniello P, Cohn JS, Wilson PWF, Schaefer EJ. Enzyme-linked immunosorbent assay for human plasma apolipoprotein B. J.Lipid Res. 1987;28:1216-24.

  104. McNamara JR, Campos H, Ordovas JM, Peterson JP, Wilson PWF, Schaefer EJ. Effect of gender, age, and lipid status on low density lipoprotein subfraction distribution. Results from the Framingham Offspring Study. Arteriosclerosis 1987;7:483-90.

  105. Levy D, Savage DD. Prevalence and clinical features of mitral valve prolapse. Am.Heart J. 1987;113:5:1281-90.

  106. Levy D, Anderson KM, Plehn JF, Savage DD, Christiansen JC, Castelli WP. Echocardiographically determined left ventricular structural and functional correlates of complex or frequent ventricular arrhythmias on one-hour ambulatory electrocardiographic monitoring. Am.J.Cardiol. 1987;59:836-30.

  107. Levy D, Anderson KM, Savage DD, Balkus SA, Kannel WB, Castelli WP. Risk of ventricular arrhythmias in left ventricular hypertrophy: the Framingham Heart Study. Am.J.Cardiol. 1987;60:560-65.

  108. Levy D, Savage DD, Garrison RJ, Anderson KM, Kannel WB, Castelli WP. Echocardiographic criteria for left ventricular hypertrophy: the Framingham Heart Study. Am.J.Cardiol. 1987;59:956-60.

  109. Levy D, Bailey JJ, Garrison RJ, Horton MR, Bak SM, Lyons D et al. Electrocardiographic changes with advancing age. A cross- sectional study of the association of age with QRS axis, duration and voltage. J.Electrocardiol. 1987;20 Suppl:44-47.

  110. Lenfant C, Stone E, Castelli WP. Celebrating 40 years of the Framingham Heart Study. J.Sch.Health 1987;57:7:279-81.

  111. Leaverton PE, Sorlie PD, Kleinman JC, Dannenberg AL, Ingster-Moore L, Kannel WB et al. Representativeness of the Framingham risk model for coronary heart disease mortality: a comparison with a national cohort study. J.Chronic.Dis. 1987;40:775-84.

  112. Kreger BE, Cupples LA, Kannel WB. The electrocardiogram in prediction of sudden death: Framingham Study experience. Am.Heart J. 1987;113:377-82.

  113. Kreger BE, Kannel WB, Cupples LA. Electrocardiographic precursors of sudden unexpected death: the Framingham Study. Circulation 1987;75:II22-II24.

  114. Kiel DP, Felson DT, Anderson JJ, Wilson PWF, Moskowitz MA. Hip fracture and the use of estrogens in postmenopausal women. The Framingham Study. N.Engl.J.Med. 1987;317:1169-74.

  115. Kannel WB, Kannel C, Paffenbarger RSJ, Cupples LA. Heart rate and cardiovascular mortality: the Framingham Study. Am.Heart J. 1987;113:1489-94.

  116. Kannel WB. Metabolic risk factors for coronary heart disease in women: Perspective from the Framingham Study. Am.Heart J. 1987;114:413-19.

  117. Kannel WB. Epidemiology and prevention of cardiac failure: Framingham Study insights. Eur.Heart J. 1987;8 Suppl F:23-26.

  118. Kannel WB, Abbott RD. Incidence and prognosis of myocardial infarction in women: the Framingham Study, In: Eaker ED, Packard B, Wenger NK, Clarkson TB, Tyroler HA, editors. Coronary Heart Disease in Women. Proceedings of an NIH Workshop. New York: Haymarket Doyma, Inc.; 1987. p. 208-14.

  119. Kannel WB, Dannenberg AL. Prevalence and natural history of electrocardiographic left ventricular hypertrophy, In: Messerli FH, editor. The Heart and Hypertension. New York: Yorke Medical Books; 1987. p. 53-61.

  120. Kannel WB, Ward GW. A decade of advances in preventive cardiology, Physician Assistant. 1987. p. 56-78.

  121. Kannel WB, Anderson KM, McGee DL, Degatano LS, Stampfer MJ. Nonspecific electrocardiographic abnormality as a predictor of coronary heart disease: the Framingham Study. Am.Heart J. 1987;113:370-76.

  122. Kannel WB. Common electrocardiographic markers for subsequent clinical coronary events. Circulation 1987;75:II25-II27.

  123. Kannel WB, Cupples LA, D'Agostino RB. Sudden death risk in overt coronary heart disease: the Framingham Study. Am.Heart J. 1987;113:799-804.

  124. Kannel WB, D'Agostino RB, Belanger AJ. Fibrinogen, cigarette smoking, and risk of cardiovascular disease: insights from the Framingham Study. Am.Heart J. 1987;113:1006-10.

  125. Kannel WB, Wolf PA, Castelli WP, D'Agostino RB. Fibrinogen and risk of cardiovascular disease. The Framingham Study. JAMA 1987;258:1183-86.

  126. Kannel WB. Cardiovascular risk factors and 'preventive management'. Hosp.Pract.[Off]. 1987;22:147-64.

  127. Kannel WB. Hypertension and other risk factors in coronary heart disease. Am.Heart J. 1987;114:918-25.

  128. Kannel WB, McGee DL. Composite scoring--methods and predictive validity: insights from the Framingham Study. Health Serv.Res. 1987;22:499-535.

  129. Kannel WB, Dannenberg AL, Levy D. Population implications of electrocardiographic left ventricular hypertrophy. Am.J.Cardiol. 1987;60:85I-93I.

  130. Kannel WB. Prevalence and clinical aspects of unrecognized myocardial infarction and sudden unexpected death. Circulation 1987;75:II4-II5.

  131. Kannel WB. Status of risk factors and their consideration in antihypertensive therapy. Am.J.Cardiol. 1987;59:80A-90A.

  132. Kannel WB, Doyle JT, Shephard RJ, Stamler J, Vokonas PS. Prevention of cardiovascular disease in the elderly. JACC 1987;10:25A-8A.

  133. Kannel WB. New perspectives on cardiovascular risk factors. Am.Heart J. 1987;114:213-19.

  134. Kannel WB, Sytkowski PA. Atherosclerosis risk factors. Pharmacol.Ther. 1987;32:207-35.

  135. Hubert HB, Eaker ED, Garrison RJ, Castelli WP. Life-style correlates of risk factor change in young adults: an eight-year study of coronary heart disease risk factors in the Framingham offspring. Am.J.Epidemiol. 1987;125:812-31.

  136. Garrison RJ, Kannel WB, Stokes JI, Castelli WP. Incidence and precursors of hypertension in young adults: the Framingham Offspring Study. Prev.Med. 1987;16:235-51.

  137. Felson DT, Naimark A, Anderson JJ, Kazis L, Castelli WP, Meenan RF. The prevalence of knee osteoarthritis in the elderly. The Framingham Osteoarthritis Study. Arthritis Rheum. 1987;30:8:914-18.

  138. Farmer ME, White LR, Kittner SJ, Kaplan E, Moes E, McNamara PM et al. Neuropsychological test performance in Framingham: A descriptive study. Psychological Reports 1987;60:1023-40.

  139. Farmer ME, White LR, Abbott RD, Kittner SJ, Kaplan E, Wolz MM et al. Blood pressure and cognitive performance. The Framingham Study. Am.J.Epidemiol. 1987;126:1103-14.

  140. Dannenberg AL, Kannel WB. Remission of hypertension. The 'natural' history of blood pressure treatment in the Framingham Study. JAMA 1987;257:1477-83.

  141. Cupples LA, D'Agostino RB, Kiely D. The Framingham Study. An Epidemiological Investigation of Cardiovascular Disease, Section 34. Some Risk Factors Related to the Annual Incidence of Cardiovascular Disease and Death Using Pooled Repeated Biennial Measurements Framingham Heart Study, 30 Year Follow-up. Bethesda, MD: National Heart, Lung, and Blood Institute; 1987.

  142. Castelli WP. [Framingham 36 years later]. Arch.Mal.Coeur. 1987;80:11-15.

  143. Castelli WP. The Framingham Heart Study - thirty years. Proc.Annu.Meet.Med.Sect.Counc.Life Insur. 1987;103-14.

  144. Castelli WP. The Framingham Heart Study - the future. Proc.Annu.Meet.Med.Sect.Counc.Life Insur. 1987;127-38.

  145. Brand FN, Wolf PA, Kannel WB. Clinical significance lone atrial fibrillation. Practical Cardiology 1987;13:9:85-93.

  146. Anderson KM, Castelli WP, Levy D. Cholesterol and mortality. 30 years of follow-up from the Framingham Study. JAMA 1987;257:2176-80.

  147. Anderson KM, Wilson PWF, Garrison RJ, Castelli WP. Longitudinal and secular trends in lipoprotein cholesterol measurements in a general population sample. The Framingham Offspring Study. Atherosclerosis 1987;68:59-66.

  148. Abbott RD, McGee DL. The Framingham Study: An Epidemiological Investigation of Cardiovascular Disease, Section 37: The Probability of Developing Certain Cardiovascular Diseases in Eight Years at Specified Values of Some Characteristics. Bethesda, MD: National Heart, Lung, and Blood Institute; 1987.

  149. Wolf PA, Kannel WB. Reduction of stroke through risk factor modification. Semin.Neurol. 1986;6:243-53.

  150. Wilson PWF, Anderson KM, Kannel WB. Epidemiology of diabetes mellitus in the elderly. The Framingham Study. Am.J.Med. 1986;80:3-9.

  151. Sperduto RD, Hiller R. Systematic hypertension and age-related maculopathy in the Framingham Study. Arch.Ophthalmol. 1986;104:216-19.

  152. Podgor MJ, Leske MC. Estimating incidence from age-specific prevalence and irreversible diseases with differential mortality. Stat.Med. 1986;5:573-78.

  153. Ordovas JM, Schaefer EJ, Salem DN, Ward RH, Glueck CJ, Vergani C et al. Apolipoprotein A-I gene polymorphism associated with premature coronary artery disease and familial hypoalphalipoproteinemia. N.Engl.J.Med. 1986;314:671-77.

  154. Levy D, Savage DD, Garrison RJ, Bailey JJ, Kannel WB, Castelli WP. Left ventricular hypertrophy: the Framingham Study, In: Bailey JJ, editor. Computerized Interpretation of the Electrocardiogram x. Proceedings of the 1985 Engineering Foundation Conference. New York: Engineering Foundation; 1986. p. 273-88.

  155. Lerner DJ, Kannel WB. Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am.Heart J. 1986;111:383-90.

  156. Kittner SJ, White LR, Farmer ME, Wolz M, Kaplan E, Moes E et al. Methodical issues in screening for dementia: The problem of education adjustment. J.Chronic.Dis. 1986;39:3:163-70.

  157. Kannel WB, Eaker ED. Psychosocial and other features of coronary heart disease: insights from the Framingham Study. Am.Heart J. 1986;112:1066-73.

  158. Kannel WB. Epidemiologic insights into atherosclerotic cardiovascular disease from the Framingham Study, In: Pollock ML, Schmidt DH, editors. Heart Disease and Rehabilitation, 2 ed. New York: John Wiley & Sons; 1986. p. 3-28.

  159. Kannel WB, McGee DL. Evaluation of cardiovascular risk, In: Stephen CR, Assaf RCE, editors. Anesthesia for Geriatric Patient.Butterworth Publishers; 1986. p. 27-53.

  160. Kannel WB. Cancer and cholesterol, Perspectives in Lipid Disorders, 3 ed. 1986. p. 9-15.

  161. Kannel WB. Cigarette smoking and peripheral arterial disease, Primary Cardiology. 1986. p. 13-17.

  162. Kannel WB, Thom TJ. Incidence, prevalence, and mortality of cardiovascular diseases, In: Hurst JW, editor. The Heart. Arteries and Veins, 6 ed. New York: McGraw-Hill Book Co.; 1986. p. 557-65.

  163. Kannel WB. Unrecognized myocardial infarction, Primary Cardiology. 1986. p. 93-105.

  164. Kannel WB, Ward GW. Overview of cardiovascular risk factors. Practical Cardiology 1986;12:1:63-75.

  165. Kannel WB, Abbott RD. A prognostic comparison of asymptomatic left ventricular hypertrophy and unrecognized myocardial infarction: the Framingham Study. Am.Heart J. 1986;111:391-97.

  166. Kannel WB, Garrison RJ, Wilson PWF. Obesity and nutrition in elderly diabetic patients. Am.J.Med. 1986;80(Suppl 5A):22-30.

  167. Kannel WB, Ward GW. Prevention of heart disease: mounting opportunities for physician action. Compr.Ther. 1986;12:6-13.

  168. Kannel WB. Hypertension. Relationship with other risk factors. Drugs 1986;31 Suppl 1:1-11.

  169. Kannel WB, Belanger AJ, D'Agostino RB, Israel I. Physical activity and physical demand on the job and risk of cardiovascular disease and death: the Framingham Study. Am.Heart J. 1986;112:820-25.

  170. Kannel WB. Silent myocardial ischemia and infarction: insights from the Framingham Study. Cardiol.Clin. 1986;4:583-91.

  171. Kannel WB. Nutritional contributors to cardiovascular disease in the elderly. J.Am.Geriatr.Soc. 1986;34:27-36.

  172. Kannel WB. Prevalence, incidence, and hazards of hypertension in the elderly. Am.Heart J. 1986;112:1362-63.

  173. Friedman LA, Kimball AW. Coronary disease mortality and alcohol consumption in Framingham. Am.J.Epidemiol. 1986;124:3:481-89.

  174. Castelli WP. The triglyceride issue: A view from Framingham. Am.Heart J. 1986;112:432-37.

  175. Castelli WP, Anderson KM. A population at risk. Prevalence of high cholesterol levels in hypertensive patients in the Framingham Study. Am.J.Med. 1986;80(Suppl 2A):23-32.

  176. Castelli WP, Garrison RJ, Wilson PWF, Abbott RD, Kalousdian S, Kannel WB. Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. JAMA 1986;256:2835-38.

  177. Abbott RD, Carroll RJ. Conditional regression models for transient state survival analysis. Am.J.Epidemiol. 1986;123:728-35.

  178. Wilson PWF, Garrison RJ, Castelli WP. Postmenopausal estrogen use, cigarette smoking, and cardiovascular morbidity in women over 50. The Framingham Study. N.Engl.J.Med. 1985;313:1038-43.

  179. Wilson PWF, Kannel WB, Anderson KM. Lipids, glucose intolerance and vascular disease: the Framingham Study. Monogr.Atheroscler. 1985;13:1-11.

  180. Stokes JI, Garrison RJ, Kannel WB. The independent contributions of various indices of obesity to the 22-year incidence of coronary heart disease: the Framingham Heart Study, In: Vague J, editor. Metabolic Complictaions of Human Obesities.Elsevier science publishers B.V. (Biomedical Division); 1985. p. 49-57.

  181. Shea S, Cook EF, Kannel WB, Goldman L. Treatment of hypertension and its effect on cardiovascular risk factors: data from the Framingham Heart Study. Circulation 1985;71:22-30.

  182. Schneider JF, Thomas HE, McNamara PM, Kannel WB. Clinical-electrocardiographic correlates of newly acquired left bundle branch block: the Framingham Study. Am.J.Cardiol. 1985;109:1332-38.

  183. Sawin CT, Castelli WP, Hershman JM, McNamara PM, Bacharach P. The aging thyroid. Thyroid deficiency in the Framingham Study. Arch.Intern.Med. 1985;145:1386-88.

  184. Savage DD, Corwin LE, McGee DL, Kannel WB, Wolf PA. Epidemiologic features of isolated syncope: the Framingham Study. Stroke 1985;16:626-29.

  185. Podgor MJ, Cassel GH, Kannel WB. Lens changes and survival in a population-based study. N.Engl.J.Med. 1985;313:1438-44.

  186. Pinsky JL, Branch LG, Jette AM, Haynes SG, Feinleib M, Cornoni-Huntley JC et al. Framingham disability study: relationship of disability to cardiovascular risk factors among persons free of diagnosed cardiovascular disease. Am.J.Epidemiol. 1985;122:4:644-56.

  187. Moscicki EK, Elkins EF, Baum HM, McNamara PM. Hearing loss in the elderly: An epidemiologic study of the Framingham Study cohort. Ear.Hear. 1985;6:8:184-90.

  188. Kannel WB, Brand FN. Cardiovascular risk factors in the elderly, In: Anders R, Bierman EL, Hazzard WR, editors. Principles of Geriatric Medicine. New York: McGraw-Hill Book Co.; 1985. p. 104-19.

  189. Kannel WB, Stokes JI. Hypertension as a cardiovascular risk factor, In: Bulpitt CJ, editor. Handbook of Hypertension. Epidemiology of Hypertension, 6 ed.Elsevier Science Publishers B.V.; 1985. p. 16-34.

  190. Kannel WB. Unrecognized myocardial infarction. CL.1 Coronary Artery Disease 1985;2:4:89-98.

  191. Kannel WB, McGee DL. Modifiable risk factors for sudden coronary death, Sudden Cardiac Death. New York: Grune & Stratton, Inc.; 1985. p. 267-84.

  192. Kannel WB. Sudden death: update from Framingham, Continuing Education. 1985. p. 493-505.

  193. Kannel WB, Stokes JI. The epidemiology of coronary artery disease, In: Cohn PF, editor. Diagnosis and Therapy of Coronary Artery Disease. Hauge/Boston/London: Martinus Nijhoff; 1985. p. 63-88.

  194. Kannel WB, McGee DL. Update on some epidemiologic features of intermittent claudication: the Framingham Study. J.Am.Geriatr.Soc. 1985;33:13-18.

  195. Kannel WB, Dannenberg AL, Abbott RD. Unrecognized myocardial infarction and hypertension: the Framingham Study. Am.Heart J. 1985;109:581-85.

  196. Kannel WB. Lipids, diabetes, and coronary heart disease: insights from the Framingham Study. Am.Heart J. 1985;110:1100-07.

  197. Kannel WB, McGee DL. Epidemiology of sudden death: insights from the Framingham Study. Cardiovasc.Clin. 1985;15:93-105.

  198. Kannel WB, Wilson PWF, Blair SN. Epidemiological assessment of the role of physical activity and fitness in development of cardiovascular disease. Am.Heart J. 1985;109:876-85.

  199. Kannel WB, Schatzkin A. Sudden death: lessons from subsets in population studies. JACC 1985;5:141B-9B.

  200. Hubert HB, Castelli WP. Obesity as a predictor of coronary heart disease, In: Frankle RT, Dwyer J, Morangne L, Owen A, editors. Dietary Treatment and Prevention of Obesity. London: John Libbey; 1985. p. 125-35.

  201. Harris TB, Cook EF, Kannel WB, Schatzkin A, Goldman L. Blood pressure experience and risk of cardiovascular disease in the elderly. Hypertension 1985;7:118-24.

  202. Halperin M, Abbott RD, Blackwelder WC, Jacobowitz R, Lan KKG, Verter JI et al. On the use of the logistic model in prospective studies. Stat.Med. 1985;4:227-35.

  203. Goetzler R, Stokes JI, Anderson KM. Prognosis of subjects in the Framingham Study with rheumatic heart disease. J.Am.Geriatr.Soc. 1985;33:10:693-97.

  204. Garrison RJ, Castelli WP. Weight and thirty-year mortality of men in the Framingham Study. Ann.Intern.Med. 1985;103):1006-09.

  205. Brand FN, McGee DL, Kannel WB, Stokes JI, Castelli WP. Hyperuricemia as a risk factor of coronary heart disease: the Framingham Study. Am.J.Epidemiol. 1985;121:11-18.

  206. Brand FN, Abbott RD, Kannel WB, Wolf PA. Characteristics and prognosis of lone atrial fibrillation. 30- year follow-up in the Framingham Study. JAMA 1985;254:3449-53.

  207. Bortnichak EA, Freeman DHJ, Ostfeld AM, Castelli WP, Kannel WB, Feinleib M et al. The association between cholesterol cholelithiasis and coronary heart disease in Framingham, Massachusetts. Am.J.Epidemiol. 1985;121:19-30.

  208. Abbott RD. Logistic regression in survival analysis. Am.J.Epidemiol. 1985;121:465-71.

  209. Wolf PA, Kannel WB, Verter JI. Epidemiologic appraisal of hypertension and stroke risk, In: Guthrie GP, Kotchen TA, editors. Hypertension and the Brain. New York: Futura Publishing Co.; 1984. p. 221-46.

  210. Wolf PA, Kerzner LJ, Hiltbrunner AV, Kannel WB. Stroke resulting from nonvalvular atrial fibrillation [clinical conference]]. J.Am.Geriatr.Soc. 1984;32:751-57.

  211. Thomas HE, Kannel WB. Diabetes and prevention of coronary heart disease, In: Podell RN, Stewart MM, editors. Primary Prevention of Coronary Heart Disease: A Practical Guide for the Clinician. Menlo Park: Addison-Wesley Publishing Co.; 1984. p. 150-70.

  212. Sperduto RD, Hiller R. The prevalence of nuclear, cortial, and posterior subscapular lens opacities in a general population sample. Ophthalmol 1984;91(7):815-18.

  213. Schatzkin A, Cupples LA, Heeren T, Morelock S, Mucatel M, Kannel WB. The epidemiology of sudden unexpected death: risk factors for men and women in the Framingham Heart Study. Am.Heart J. 1984;107:1300-06.

  214. Schatzkin A, Cupples LA, Heeren T, Morelock S, Kannel WB. Sudden death in the Framingham Heart Study. Differences in incidence and risk factors by sex and coronary disease status. Am.J.Epidemiol. 1984;120:888-99.

  215. Sacco RL, Wolf PA, Bharucha NE, Meeks SL, Kannel WB, Charette LJ et al. Subarachnoid and intracerebral hemorrhage: natural history, prognosis, and precursive factors in the Framingham Study. Neurology 1984;34:847-54.

  216. Kannel WB, Brand FN. Can a routine lung function test warn of heart trouble? J.Resp.Dis. 1984;18:5(10):39-47.

  217. Kannel WB, McGee DL, Castelli WP. Latest perspectives on cigarrette smoking and cardiovascular disease: the Framingham Study. J.Cardiac.Rehabil. 1984;4:267-77.

  218. Kannel WB. Hypertensive disease in the elderly: a consequence of arteriosclerosis or blood pressure?, In: Bergener M, Grobecker H, editors. 10. Rothenburger Gesprach, 16.-18. Mai 1984. New York: F.K. Schattauer Verlag; 1984. p. 31-50.

  219. Kannel WB, Abbott RD. Incidence and prognosis of unrecognized myocardial infarction: based on 26-years follow-up in the Framingham Study, In: Rutishauser W, Roskamm H, editors. Silent Myocardial Ischemia. New York: Springer-Verlag; 1984. p. 131-37.

  220. Kannel WB. Pediatric aspects of lipid-induced atherogenesis. J.Am.Coll.Nutr. 1984;3:139-46.

  221. Kannel WB, Abbott RD. Incidence and prognosis of unrecognized myocardial infarction. An update on the Framingham Study. N.Engl.J.Med. 1984;311:1144-47.

  222. Kannel WB, Stampfer MJ, Castelli WP, Verter JI. The prognostic significance of proteinuria: the Framingham Study. Am.Heart J. 1984;108:1347-52.

  223. Kannel WB, McGee DL, Schatzkin A. An epidemiological perspective of sudden death. 26-year follow- up in the Framingham Study. Drugs 1984;28 Suppl 1:1-16.

  224. Kannel WB, Schatzkin A. Risk factor analysis. Prog.Cardiovasc.Dis. 1984;26:309-20.

  225. Higgins MW. The Framingham Heart Study: A review of epidemiological design and data, limitations and prospects, Genetic Epidemiology of Coronary Heart Diseases: Past, Present and Future. New York: Alan R. Liss, Inc.; 1984. p. 51-64.

  226. Heller R, Garrison RJ, Havlik RJ, Feinleib M, Padgett SJ. Family resemblances in height and relative weight in the Framingham Heart Study. Int J Obes 1984;8:5:399-405.

  227. Gore JM, Goldberg RJ, Matsumoto AS, Castelli WP, McNamara PM, Dalen JE. Validity of serum total cholesterol level obtained within 24 hours of acute myocardial infarction. Am.J.Cardiol. 1984;54:722-25.

  228. Gordon T, Kannel WB. Drinking and mortality. The Framingham Study. Am.J.Epidemiol. 1984;120:97-107.

  229. Ferris FL, Fine SL, Hyman L. Age related macular degeneration and blindness due to neovascular malculpathy. Arch.Ophthalmol. 1984;102:1640-42.

  230. Castelli WP. Epidemiology of coronary heart disease: the Framingham Study. Am.J.Med. 1984;76:4-12.

  231. Carroll RJ, Speigelman CH, Lan KKG, Abbott RD. On errors-in-variables for binary regression models. Biometrika 1984;71:1:19-25.

  232. Abbott RD, Carroll RJ. Interpreting multiple logistic regression coefficients in prospective observational studies. Am.J.Epidemiol. 1984;119:830-36.

  233. Abbott RD, Garrison RJ, Wilson PWF. Framingham Heart Study data on females using estrogen supplements [letter]]. Arteriosclerosis 1984;4:517.

  234. Wolf PA, Kannel WB, McGee DL, Meeks SL, Bharucha NE, McNamara PM. Duration of atrial fibrillation and imminence of stroke: the Framingham Study. Stroke 1983;14:664-67.

  235. Wolf PA, Savage DD, Kannel WB, Castelli WP. Mitral valve prolapse and risk of stroke [letter]]. Stroke 1983;14:1010-12.

  236. Wolf PA, Kannel WB, Verter JI. Current status of risk factors for stroke. Neurol.Clin. 1983;1:317-43.

  237. Wilson PWF, Savage DD, Castelli WP, Garrison RJ, Donahue RP, Feinleib M. HDL-cholesterol in a sample of black adults: the Framingham Minority Study. Metabolism 1983;32:328-32.

  238. Wilson PWF, Garrison RJ, Abbott RD, Castelli WP. Factors associated with lipoprotein cholesterol levels. The Framingham Study. Arteriosclerosis 1983;3:273-81.

  239. Savage DD, Castelli WP, Abbott RD, Garrison RJ, Anderson SJ, Kannel WB et al. Hypertrophic cardiomyopathy and its markers in the general population: The great masquerader revisited: the Framingham Study. J.Cardiovasc.Ultrasonography 1983;2(1):41-47.

  240. Savage DD, Abbott RD, Kannel WB. Chronic atrial fibrillation in the general population. Primary Cardiol. 1983;49-64.

  241. Savage DD, Garrison RJ, Brand FN, Anderson SJ, Castelli WP, Kannel WB et al. Prevalence and correlates of posterior extra echocardiographic spaces in a free-living population based sample (the Framingham Study). Am.J.Cardiol. 1983;51:1207-12.

  242. Savage DD, Garrison RJ, Castelli WP, McNamara PM, Anderson SJ, Kannel WB et al. Prevalence of submitral (anular) calcium and its correlates in a general population-based sample (the Framingham Study). Am.J.Cardiol. 1983;51:1375-78.

  243. Savage DD, Castelli WP, Anderson SJ, Kannel WB. Sudden unexpected death during ambulatory electrocardiographic monitoring. The Framingham Study. Am.J.Med. 1983;74:148-52.

  244. Savage DD, Garrison RJ, Devereux RB, Castelli WP, Anderson SJ, Levy D et al. Mitral valve prolapse in the general population. 1. Epidemiologic features: the Framingham Study. Am.Heart J. 1983;106:571-76.

  245. Savage DD, Devereux RB, Garrison RJ, Castelli WP, Anderson SJ, Levy D et al. Mitral valve prolapse in the general population. 2. Clinical features: the Framingham Study. Am.Heart J. 1983;106:577-81.

  246. Savage DD, Levy D, Garrison RJ, Castelli WP, Kligfield P, Devereux RB et al. Mitral valve prolapse in the general population. 3. Dysrhythmias: the Framingham Study. Am.Heart J. 1983;106:582-86.

  247. Podgor MJ, Leske MC, Ederer F. Incidence estimates for lens changes, macular changes, open- angle glaucoma and diabetic retinopathy. Am.J.Epidemiol. 1983;118(2):206-12.

  248. Phillips GB, Castelli WP, Abbott RD, McNamara PM. Association of hyperestrogenemia and coronary heart disease in men in the Framingham cohort. Am.J.Med. 1983;74:863-69.

  249. Leske MC, Podgor MJ. Intraocular pressure, cardiovascular risk variables, and visual field defects. Am.J.Epidemiol. 1983;118:280-87.

  250. Kannel WB, Brand FN. Cardiovascular risk factors in the elderly woman, In: Markson EW, editor. Older women: Issues and Prospects. Lexington: D.C. Health and Co.; 1983. p. 315-27.

  251. Kannel WB, Hubert HB, Lew EA. Vital capacity as a predictor of cardiovascular disease: the Framingham Study. Am.Heart J. 1983;105:311-15.

  252. Kannel WB, Abbott RD, Savage DD, McNamara PM. Coronary heart disease and atrial fibrillation: the Framingham Study. Am.Heart J. 1983;106:389-96.

  253. Kannel WB. Prevalence and natural history of electrocardiographic left ventricular hypertrophy. Am.J.Med. 1983;75:4-11.

  254. Kannel WB, Wolf PA, Verter JI. Manifestations of coronary disease predisposing to stroke. The Framingham Study. JAMA 1983;250:2942-46.

  255. Kannel WB. High-density lipoproteins: epidemiologic profile and risks of coronary artery disease. Am.J.Cardiol. 1983;52:9B-12B.

  256. Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 1983;67:968-77.

  257. Hofman A, Feinleib M, Garrison RJ, VanLaar A. Does a change in blood pressure predict heart disease? Br.Med.J. 1983;287:267-69.

  258. Haynes SG, Eaker ED, Feinleib M. Spouse behavior and coronary heart disease in men: Prospective results from the Framingham Heart Study. I. Concordence of risk factors and the relationship of psychosocial status to coronary incidence. Am.J.Epidemiol. 1983;118:1-22.

  259. Gordon T, Kannel WB. Drinking and its relation to smoking, bp, blood lipids, and uric acid. Arch.Intern.Med. 1983;143:1366-74.

  260. Gordon T, Kannel WB. Drinking habits and cardiovascular disease: the Framingham Study. Am.Heart J. 1983;105:667-73.

  261. Goldhaber SZ, Savage DD, Garrison RJ, Castelli WP, Kannel WB, McNamara PM et al. Risk factors for pulmonary embolism. The Framingham Study. Am.J.Med. 1983;74:1023-28.

  262. Garrison RJ, Feinleib M, Castelli WP, McNamara PM. Cigarette smoking as a confounder of the relationship between relative weight and long-term mortality. The Framingham Heart Study. JAMA 1983;249:2199-203.

  263. Eaker ED, Haynes SG, Feinleib M. Spouse behavior and coronary heart disease in men: Prospective results from the Framingham Heart Study. II. Modification of risk in Type A husbands according to the social and psychological status of their wives. Am.J.Epidemiol. 1983;118:23-41.

  264. Castelli WP, Abbott RD, McNamara PM. Summary estimates of cholesterol used to predict coronary heart disease. Circulation 1983;67:730-34.

  265. Castelli WP. Cardiovascular disease and multifactorial risk: challenge of the 1980s. Am.Heart J. 1983;106:1191-2000.

  266. Abbott RD, Garrison RJ, Wilson PWF, Epstein FH, Castelli WP, Feinleib M et al. Joint distribution of lipoprotein cholesterol classes. The Framingham Study. Arteriosclerosis 1983;3:260-72.

  267. Sorlie PD, Feinleib M. The serum cholesterol-cancer relationship: an analysis of time trends in the Framingham Study. J.Natl.Cancer Inst. 1982;69:989-96.

  268. Snowden CB, McNamara PM, Garrison RJ, Feinleib M, Kannel WB, Epstein FH. Predicting coronary heart disease in siblings--a multivariate assessment: the Framingham Heart Study. Am.J.Epidemiol. 1982;115:217-22.

  269. Seigel D, Sperduto RD, Ferris FL. Aspirin and cataracts. Ophthalmol 1982;89:47A-9A.

  270. Sacco RL, Wolf PA, Kannel WB, McNamara PM. Survival and recurrence following stroke. The Framingham Study. Stroke 1982;13:290-95.

  271. Kannel WB, Thomas HE. Sudden coronary death: the Framingham Study. Ann.N.Y.Acad.Sci. 1982;382:3-21.

  272. Kannel WB. Meaning of the downward trend in cardiovascular mortality. JAMA 1982;247:877-80.

  273. Kannel WB, Abbott RD, Savage DD, McNamara PM. Epidemiologic features of chronic atrial fibrillation: the Framingham Study. N.Engl.J.Med. 1982;306:1018-22.

  274. Kannel WB, Gordon T. The search for an optimum serum cholesterol. Lancet 1982;2:374-75.

  275. Hubert HB, Holford TR, Kannel WB. Clinical characteristics and cigarette smoking in relation to prognosis of angina pectoris in Framingham. Am.J.Epidemiol. 1982;115:231-42.

  276. Hiller R, Sperduto RD, Krueger DF. Pseudoexfoliation, intraocular pressure, and senile lens changes in a population-based survey. Arch.Ophthalmol. 1982;100:1080-82.

  277. Haynes SG, Feinleib M, Eaker ED. Type A behavior and the ten year incidence of coronary heart disease in the Framingham Heart Study. Act.Nerv.Super.(Praha) 1982;3:57-77.

  278. Haynes SG, Feinleib M. Type A behavior and the incidence of coronary heart disease in the Framingham Heart Study. Adv.Cardiol. 1982;29:85-95.

  279. Gordon T, Kannel WB. Multiple risk functions for predicting coronary heart disease: the concept, accuracy, and application. Am.Heart J. 1982;103:1031-39.

  280. Dawber TR, Nickerson RJ, Brand FN, Pool J. Eggs, serum cholesterol, and coronary heart disease. Am.J.Clin.Nutr. 1982;36:617-25.

  281. Corwin LE, Wolf PA, Kannel WB, McNamara PM. Accuracy of death certification of stroke: the Framingham Study. Stroke 1982;13:818-21.

  282. Castelli WP. Clinical risk factors in coronary disease. The Framingham Study. Wien.Med.Wochenschr. 1982;132:I.

  283. Blackwelder WC, Mittal KK, McNamara PM, Payne FJ. Lack of association between HLA and age in an aging population. Tissue Antigens 1982;20:188-92.

  284. Blackwelder WC, Dolin R, Mittal KK, McNamara PM, Payne FJ. A population study of herpesvirus infections and HLA antigens. Am.J.Epidemiol. 1982;115(4):569-76.

  285. Abbott RD, Garrison RJ, Wilson PWF, Castelli WP. Coronary heart disease risk: the importance of joint relationships among cholesterol levels in individual lipoprotein classes. Prev.Med. 1982;11:131-41.

  286. Wolf PA, Kannel WB, Sorlie PD, McNamara PM. Asymptomatic carotid bruit and risk of stroke. The Framingham Study. JAMA 1981;245:1442-45.

  287. Wilson PWF, McGee DL, Kannel WB. Obesity, very low density lipoproteins, and glucose intolerance over fourteen years: the Framingham Study. Am.J.Epidemiol. 1981;114:697-704.

  288. Wilson PWF, Abbott RD, Garrison RJ, Castelli WP. Estimation of very-low-density lipoprotein cholesterol from data on triglyceride concentration in plasma. Clin.Chem. 1981;27:2008-10.

  289. Williams RR, Sorlie PD, Feinleib M, McNamara PM, Kannel WB, Dawber TR. Cancer incidence by levels of cholesterol. JAMA 1981;245:247-52.

  290. Sperduto RD, Hiller R, Seigel D. Lens opacities and senile maculpathy. Arch.Ophthalmol. 1981;99:1004-08.

  291. Schneider JF, Thomas HEJ, Sorlie PD, Kreger BE, McNamara PM, Kannel WB. Comparative features of newly acquired left and right bundle branch block in the general population: the Framingham Study. Am.J.Cardiol. 1981;47:931-40.

  292. Kannel WB. Prospects for risk factor modification to reduce risk of reinfarction and premature death. JCR 1981;(1)1:63-71.

  293. Kannel WB, Wolf PA, McGee DL, Dawber TR, McNamara PM, Castelli WP. Systolic blood pressure, arterial rigidity, and risk of stroke. The Framingham Study. JAMA 1981;245:1225-29.

  294. Kannel WB, Gordon T, Castelli WP. Role of lipids and lipoprotein fractions in atherogenesis: the Framingham Study. Prog.Lipid Res. 1981;20:339-48.

  295. Kannel WB. Update on the role of cigarette smoking in coronary artery disease. Am.Heart J. 1981;101:319-28.

  296. Jette AM, Branch LG. The Framingham Disability Study: II. Physical disability among the aging. Am.J.Public Health 1981;71(11):1211-16.

  297. Gordon T, Kagan A, Garcia-Palmieri MR, Kannel WB, Zukel WJ, Tillotson J et al. Diet and its relation to coronary heart disease and death in three populations. Circulation 1981;63:500-15.

  298. Gordon T, Kannel WB, Castelli WP, Dawber TR. Lipoproteins, cardiovascular disease, and death. The Framingham Study. Arch.Intern.Med. 1981;141:1128-31.

  299. Feinleib M. On a possible inverse relationship between serum cholesterol and cancer mortality. Am.J.Epidemiol. 1981;114:5-10.

  300. Ederer F, Hiller R, Taylor HR. Senile lens changes and diabetes in two population studies. Am.J.Ophthalmol. 1981;91:381-95.

  301. Castelli WP, Garrison RJ, Dawber TR, McNamara PM, Feinleib M, Kannel WB. The filter cigarette and coronary heart disease: the Framingham story. Lancet 1981;2:109-13.

  302. Branch LG, Jette AM. The Framingham Disability Study: I. Social disability among the aging. Am.J.Public Health 1981;71(11):1202-10.

  303. Wu M. Time-of-measurement effects in longitudinal studies. J.Chronic.Dis. 1980;33:207-13.

  304. Wu M, Ware JH, Feinleib M. On the relation between blood pressure change and initial value. J.Chronic.Dis. 1980;33:637-44.

  305. Wilson PWF, Garrison RJ, Castelli WP, Feinleib M, McNamara PM, Kannel WB. Prevalence of coronary heart disease in the Framingham Offspring Study: role of lipoprotein cholesterols. Am.J.Cardiol. 1980;46:649-54.

  306. Sperduto RD, Seigel D. Senile lens and senile macular changes in a population-based sample. Am.J.Ophthalmol. 1980;90:86-91.

  307. Sorlie PD, Gordon T, Kannel WB. Body build and mortality. The Framingham Study. JAMA 1980;243:1828-31.

  308. Schneider JF, Thomas HE, Kreger BE, McNamara PM, Sorlie PD, Kannel WB. Newly acquired right bundle-branch block: the Framingham Study. Ann.Intern.Med. 1980;92:37-44.

  309. Rosenthal A. The Framingham Eye Study: An Editorial. Surv.Ophthalmol. 1980;24:611-13.

  310. Leibowitz HM, Krueger DF, Maunder LR, Milton RC, Kini MM, Kahn HA et al. The Framingham Eye study monograph. Surv.Ophthalmol. 1980;24(Suppl):335-610.

  311. Krueger DF, Milton RC, Maunder LR. The Framingham Eye Study: Introduction to the monograph. Surv.Ophthalmol. 1980;24:614-20.

  312. Kannel WB, Sorlie PD. Remissions of angina pectoris. Primary Cardiol. 1980;27-36.

  313. Kannel WB, Sorlie PD, Brand FN, Castelli WP, McNamara PM, Gherardi G. Epidemiology of coronary atherosclerosis: postmortem vs clinical risk factor correlations: the Framingham Study, Artherosclerosis-V. New York: New York Springer-Verlag; 1980. p. 54-56.

  314. Kannel WB, Sorlie PD, Castelli WP, McGee DL. Blood pressure and survival after myocardial infarction: the Framingham Study. Am.J.Cardiol. 1980;45:326-30.

  315. Kannel WB, Dawber TR, McGee DL. Perspectives on systolic hypertension. The Framingham Study. Circulation 1980;61:1179-82.

  316. Kannel WB, Sorlie PD, Gordon T. Labile hypertension: a faulty concept? The Framingham Study. Circulation 1980;61:1183-87.

  317. Kannel WB, Lew EA, Hubert HB, Castelli WP. The value of measuring vital capacity for prognostic purposes. Trans.Assoc.Life Insur.Med.Dir.Am. 1980;64:66-81.

  318. Kahn HA, Milton RC. Revised Framingham Eye Study prevalence of glaucoma and diabetic retinopathy. Am.J.Epidemiol. 1980;111:769-76.

  319. Kahn HA, Milton RC. Alternative definitions of open-angle glaucoma. Effect on prevalence and associations in the Framingham Eye Study. Arch.Ophthalmol. 1980;98:2172-77.

  320. Haynes SG, Feinleib M, Kannel WB. The relationship of psychosocial factors to coronary heart disease in the Framingham Study. III. Eight-year incidence of coronary heart disease. Am.J.Epidemiol. 1980;111:37-58.

  321. Haynes SG, Feinleib M. Women, work and coronary heart disease: prospective findings from the Framingham Heart Study. Am.J.Public Health 1980;70:133-41.

  322. Havlik RJ, Garrison RJ, Feinleib M, Padgett SJ, Castelli WP, McNamara PM. Evidence for additional blood pressure correlates in adults 20- 56 years old. Circulation 1980;61:710-15.

  323. Garrison RJ, Wilson PWF, Castelli WP, Feinleib M, Kannel WB, McNamara PM. Obesity and lipoprotein cholesterol in the Framingham Offspring Study. Metabolism 1980;29:1053-60.

back to Framingham Main Bibliography Page back to Framingham Home Page




Please send us your feedback, comments, and questions
by using the appropriate link on the page, Contact the NHLBI.

Note to users of screen readers and other assistive technologies: please report your problems here.